Watch for results of SNGX speaking at Cantor Fitzgerald Global Healthcare Conference today 9/29. Imagine the Big-Pharma eyes & interest for SNGX's "Temp controlled" vaccines (including COVID) at this conference. Big Pharma interest for sure...
"Soligenix, Inc. (NASDAQ:SNGX) , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will participate in a fireside chat hosted by Kristen Kluska, Director, Equity Research, at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00AM ET. In addition to the fireside chat, Dr. Schaber will be available to participate in virtual one-on-one meetings with those who are registered to attend. A webcast of the live fireside chat will be available following the event, please visithttps://wsw.com/webcast/cantor12/sngx/2112320.